Blog

Transitioning from a PhD in Computational Biology to developing software

Interview by Wendy Tindsley An interview with Andrea Martinez Vernon, Computational Biologist at Aigenpulse At Aigenpulse we are proud that we attract the best talent on the market. Whilst this often takes the form of established hires, i.e. those who have worked in the industry for a number of years, we also heavily rely on […]

Cutting-Edge Biotechs Need Cutting-Edge Software

The April edition of Genetic Engineering News contains an article by Dr Satnam Surae, Aigenpulse Chief Product Officer, on how Cutting-Edge Biotechs Need Cutting-Edge Software. Don’t let your life sciences data become a bloated mess. Ensure that, however much your data grows, it stays relevant and accessible. How? Use an intelligence platform, says Aigenpulse’s Satnam […]

Digitally improving FACS workflows the ‘Aigenpulse Way’

Above, Carlos del Ojo Elias – Senior Bioinformatician of the Software Engineering A-Team at Aigenpulse! In this post,we’re going to talk about how to address the challenges of automating an entire FACS workflow, while maintaining the quality and tractability of the process. This post is for you if you create, manage or interpret FACS data.  The Complexity of FACS Data  […]

Why ISO for Aigenpulse?

Our press release is here, but before you read that, we thought it would be useful to understand exactly why and how we undertook this journey into achieving internationally recognised standards. Our Quality Story “Trust, Respect, Diversity” – Aigenpulse’s Core Values This was our motto when we started to develop our Business Management System in […]

What are the challenges and opportunities for Life Science Post Brexit?

The FierceBiotech Executive Summit, Royal Society of Medicine, London October 30th, 2018 For someone who tries to keep up with Brexit by listening to the Brexitcast, I was interested to hear, more specifically, what the Life Sciences sector feels about Brexit. There was a lively panel discussion between Dr Munna Choudury of Accenture and Alacramed, […]

Keynote highlights of ELRIG Drug Discovery 2018

Two behemoths of UK life science gave inspirational keynotes on both days of ELRIG Drug Discovery 2018. Both talks shared a theme of making ageing more bearable to enable people to get older, but remain healthy. And ambitiously, to simultaneously maintain quality of life whilst reducing the burden of ageing on increasingly stretched healthcare providers. […]